Alemtuzumab therapy in B-cell lymphoproliferative disorders.

Alemtuzumab therapy in B-cell lymphoproliferative disorders.

Item
http://www.wikidata.org/entity/Q35206362
Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy.Alemtuzumab in clinical practice: a British Columbia experience.Recent advances in chronic lymphocytic leukemia.Sensitizing protective tumor microenvironments to antibody-mediated therapy.The Syk kinase as a therapeutic target in leukemia and lymphoma.Fully human antibody exhibits pan-human leukocyte antigen-DR recognition and high in vitro/vivo efficacy against human leukocyte antigen-DR-positive lymphomas.The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia.
P2860

Alemtuzumab therapy in B-cell lymphoproliferative disorders.

Item
http://www.wikidata.org/entity/Q35206362
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@ast
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@en
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@en-gb
type
label
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@ast
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@en
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@en-gb
prefLabel
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@ast
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@en
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@en-gb
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
@en
P2093
P304
P31
P356
10.1016/S0093-7754(03)00253-7
P433
P478
P50
P577
P698